Advanced Research Fellow @ IMS & John Mallard Scottish PET centre. Opinions are my own.
Joined August 2017
- Tweets 601
- Following 367
- Followers 292
- Likes 1,063
67 Photos and videos
S Dall'Angelo retweeted
🧑⚕️ Thinking about studying medicine - or know someone who is? Join us on Saturday 6 June for our Medicine Open Day and discover what it’s like to study medicine at the University of Aberdeen. Register now ➡️ abdn.io/2e3 #StudyMedicine #MedicineOpenDay
3
2
252
S Dall'Angelo retweeted
Researchers @aberdeenuni have been awarded a 5-year programme grant of over £1.1 million from @TheBHF. The funding will support work on a new approach to reducing the build-up of fat in the arteries, lowering the risk of heart diseases ➡️ abdn.io/2ds
ALT Photo of Professor Mirela Delibegovic
1
1
4
116
S Dall'Angelo retweeted
✨ Our April Trailblazer is here!
We’re featuring Sergio Dall’Angelo (@_SDallAngelo_), Lecturer at the @aberdeenuni.
☢️ His work spans peptides, small molecules & PET radiotracers.
🥼 Read more ↓
#Trailblazers #UKPETChem #PETChemistry #Radiochemistry #MolecularImaging
1
2
44
19 Nov 2025
🚨Great PhD opportunity in collaboration with @jennagregory488 and @GregoryLab7. linkedin.com/posts/sergio-da…
1
1
76
17 Nov 2025
Check out this job at Radella Pharmaceuticals LLC: Biologist linkedin.com/jobs/view/43231…
42
S Dall'Angelo retweeted
@mdelibeg preprint entitled "Myeloid cell protein tyrosine phosphatase 1B (PTP1B) drives retinal neurodegeneration in diabetic mice" is now @ BioRxiv biorxiv.org/content/10.1101/… @AbdnLifeScience @BHFScotland @TheBHF @NHSGrampian
1
3
5
348
25 Sep 2025
Andrea Testa back in Aberdeen as Guest lecturer.
Guest Lecture tomorrow evening (Friday 26th).
All welcome
1
2
72
27 Sep 2025
What an AMAZING ✨talk! Well done Andrea! Such a great journey! 👏
1
1
15
S Dall'Angelo retweeted
Guest Lecture tomorrow evening (Friday 26th).
All welcome
2
1
129
S Dall'Angelo retweeted
15 Sep 2025
Dr Iain Greig and a team of international experts have received funding to develop a treatment that could halt MS progression and even repair nerve damage to restore previously lost functions - something never achieved previously. abdn.io/1FS
3
13
1,246
S Dall'Angelo retweeted
10 Sep 2025
9 Sep 2025
Congratulations to @hollymcerlain, winner of best flash presentation and poster runner up! #UKPET (@UofGChem)
1
2
118
9 Sep 2025
Amazing Key Note Talk by @LewisLabMSKCC #UKPETChem ☢️⚗️2025. Always inspiring and energising!
2
4
342
8 Sep 2025
On my way to Glasgow to attend the UK PET Chemistry Meeting ☢️⚗️🧪. What an amazing day to travel by train 🚆.
#UKPETChem #PositronPulse
1
6
130
7 Sep 2025
Can’t wait!!! ☢️🧪
7 Sep 2025
Ready for the UK PET Chemistry Meeting this Tuesday (9 Sept) in Glasgow? A one-day forum for students, ECRs & industry to share science and connect. Keynote: Prof Jason Lewis. Venue: Sir Charles Wilson Building, UofG. Tag us use #UKPETChem #PositronPulse
3
108
S Dall'Angelo retweeted
7 Sep 2025
Ready for the UK PET Chemistry Meeting this Tuesday (9 Sept) in Glasgow? A one-day forum for students, ECRs & industry to share science and connect. Keynote: Prof Jason Lewis. Venue: Sir Charles Wilson Building, UofG. Tag us use #UKPETChem #PositronPulse
2
5
455
S Dall'Angelo retweeted
Dr Claire Whyte presenting a novel coronary artery flow model in the ‘Novel Experimental models in haemostasis & thrombosis’ session at #ISTH2025
Presenting on behalf of her PhD student Stephen Humphreys🧑🔬
4
5
808
S Dall'Angelo retweeted
14 Jun 2025
So delighted to host the 2025 RSC Chemical Biology and Bioorganic Group Postgraduate Symposium at The University of Aberdeen. We had a very successful event and excellent presentations.
1
2
11
515
1 Jun 2025
The Body Game is at @TechFestNews today! Come and have a go!!
Thanks to our PhD students 🧑🎓👩🎓Jamie Innes, Rebekah Wood, Sara Sharaf, Maheshika Kurukukasuriya and Ruaridh Dall for helping out and to @RoySocChem 🧪for supporting the project!
@ProfJohnBarrow
1
7
194
S Dall'Angelo retweeted
In the same week that Pfizer decided to discontinue the development of danuglipron, an oral, small-molecule GLP-1 receptor agonist aimed at chronic weight management ➡️ Lilly report a successful Phase 3 trial with Orforglipron, lowering A1C and body weight😃
17 Apr 2025
🚨BREAKING: Lilly’s oral GLP-1, orforglipron, hits its primary endpoint in the Phase 3 ACHIEVE-1 trial for type 2 diabetes.
🔸A1C↓ by 1.3–1.6%
🔸Weight loss: up to 16 lbs (7.9%)
🔸65% hit A1C ≤6.5%
Once-daily, oral small molecule GLP-1—no food/water restrictions
Safety profile: consistent with injectable GLP-1s
✨ The first oral small molecule GLP-1 to complete Phase 3—game on.
#GLP1 #orforglipron #T2D #ObesityCare #ACHIEVE1
prnewswire.com/news-releases…
2
3
5
712